A012303: ShortStop-HER2

Who Can Participate in the Study?

Age Group
Adults

Study Details

Full Title
Protocol A012303, ShortStop-HER2: Shortened duration of adjuvant therapy in patients with early-stage HER2+ breast cancer who achieve pCR after neoadjuvant chemotherapy with HER2 blockade.
Principal Investigator
Headshot of Neha Verma
Assistant Professor of Medicine
Protocol Number
IRB: PRO00119313
NCT: NCT06876714
Phase
Phase III
ClinicalTrials.gov
Enrollment Status
OPEN TO ACCRUAL